Yifat Merbl

2.9k total citations
42 papers, 1.5k citations indexed

About

Yifat Merbl is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yifat Merbl has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yifat Merbl's work include Ubiquitin and proteasome pathways (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Advanced Biosensing Techniques and Applications (7 papers). Yifat Merbl is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Advanced Biosensing Techniques and Applications (7 papers). Yifat Merbl collaborates with scholars based in Israel, United States and India. Yifat Merbl's co-authors include Marc W. Kirschner, Irun R. Cohen, Francisco J. Quintana, Merav Zucker‐Toledano, Ying Huo, Jennifer L. Gallop, Tao Wu, Amit Tzur, Eytan Domany and Avital Eisenberg‐Lerner and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yifat Merbl

39 papers receiving 1.5k citations

Peers

Yifat Merbl
Maurice Zauderer United States
Lakshmi Amaravadi United States
Warren Kaplan Australia
Terence G. Porter United States
Janet H. Scott United States
Jeffrey West United States
Yifat Merbl
Citations per year, relative to Yifat Merbl Yifat Merbl (= 1×) peers Jean-Philippe Stéphan

Countries citing papers authored by Yifat Merbl

Since Specialization
Citations

This map shows the geographic impact of Yifat Merbl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifat Merbl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifat Merbl more than expected).

Fields of papers citing papers by Yifat Merbl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifat Merbl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifat Merbl. The network helps show where Yifat Merbl may publish in the future.

Co-authorship network of co-authors of Yifat Merbl

This figure shows the co-authorship network connecting the top 25 collaborators of Yifat Merbl. A scholar is included among the top collaborators of Yifat Merbl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifat Merbl. Yifat Merbl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kim, Min Woo, Taitea Dykstra, Siling Du, et al.. (2024). Engineered T cell therapy for central nervous system injury. Nature. 634(8034). 693–701. 21 indexed citations
3.
Markandey, Manasvini, Gayatree Mohapatra, Subhash Chandra Yadav, et al.. (2024). Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis. eLife. 12. 1 indexed citations
4.
Markandey, Manasvini, Gayatree Mohapatra, Subhash Chandra Yadav, et al.. (2023). Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis. eLife. 12. 1 indexed citations
5.
Levy, Ronen, Wayne Paes, Osnat Bartok, et al.. (2023). Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes. Molecular & Cellular Proteomics. 22(4). 100519–100519. 11 indexed citations
6.
Sheban, Daoud & Yifat Merbl. (2023). EMSY stabilization in KEAP1-mutant lung cancer disrupts genome stability and type I interferon signaling. Cell Death and Differentiation. 30(5). 1397–1399. 3 indexed citations
7.
Kacen, Assaf, Aaron Javitt, Matthias P. Kramer, et al.. (2022). Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nature Biotechnology. 41(2). 239–251. 67 indexed citations
8.
Ulman, Adi, Bareket Dassa, Aaron Javitt, et al.. (2021). Altered Protein Abundance and Localization Inferred from Sites of Alternative Modification by Ubiquitin and SUMO. Journal of Molecular Biology. 433(21). 167219–167219. 5 indexed citations
9.
Reznik, Nava, Noga Kozer, Avital Eisenberg‐Lerner, et al.. (2019). Phenotypic Screen Identifies JAK2 as a Major Regulator of FAT10 Expression. ACS Chemical Biology. 14(12). 2538–2545. 2 indexed citations
10.
Javitt, Aaron, Avital Eisenberg‐Lerner, Assaf Kacen, et al.. (2018). Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides. Nature Biotechnology. 36(11). 1110–1116. 33 indexed citations
11.
Eisenberg‐Lerner, Avital, et al.. (2017). Post-Translational Modification Profiling-Functional Proteomics for the Analysis of Immune Regulation. Methods in molecular biology. 1647. 139–152. 3 indexed citations
12.
Merbl, Yifat, et al.. (2013). Profiling of Ubiquitin-like Modifications Reveals Features of Mitotic Control. Cell. 152(5). 1160–1172. 87 indexed citations
13.
Madi, Asaf, Dror Y. Kenett, Sharron Bransburg‐Zabary, et al.. (2011). Network Theory Analysis of Antibody-Antigen Reactivity Data: The Immune Trees at Birth and Adulthood. PLoS ONE. 6(3). e17445–e17445. 31 indexed citations
14.
Merbl, Yifat & Marc W. Kirschner. (2010). Protein microarrays for genome‐wide posttranslational modification analysis. WIREs Systems Biology and Medicine. 3(3). 347–356. 14 indexed citations
15.
Madi, Asaf, Inbal Hecht, Sharron Bransburg‐Zabary, et al.. (2009). Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data. Proceedings of the National Academy of Sciences. 106(34). 14484–14489. 71 indexed citations
16.
Merbl, Yifat, Merav Zucker‐Toledano, Francisco J. Quintana, & Irun R. Cohen. (2007). Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. Journal of Clinical Investigation. 117(3). 712–718. 176 indexed citations
17.
Greenbaum, Lior, Rael D. Strous, Kyra Kanyas, et al.. (2007). Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenetics and Genomics. 17(7). 519–528. 42 indexed citations
18.
Strous, Rael D., Lior Greenbaum, Kyra Kanyas, et al.. (2006). Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication. The International Journal of Neuropsychopharmacology. 10(3). 321–321. 18 indexed citations
19.
Greenbaum, Lior, Kyra Kanyas, Osnat Karni, et al.. (2005). Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Molecular Psychiatry. 11(3). 312–322. 86 indexed citations
20.
Merbl, Yifat, et al.. (2004). Vessel maturation effects on tumour growth: validation of a computer model in implanted human ovarian carcinoma spheroids. European Journal of Cancer. 41(1). 159–167. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026